We are live on
!
Find out more
2L
22NW LP Portfolio holdings
AUM
$146M
1-Year Est. Return
29.83%
This Fund
S&P 500
This Quarter
Est. Return
+15.61%
1 Year Est. Return
+29.83%
3 Year Est. Return
+131.37%
5 Year Est. Return
+199.25%
10 Year Est. Return
–
AUM
$159M
AUM Growth
+$39.2M
(+33%)
Cap. Flow
+$23.4M
Cap. Flow
% of AUM
14.79%
Top 10 Holdings %
Top 10 Hldgs %
93.11%
Holding
16
New
3
Increased
2
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANEB
Anebulo Pharmaceuticals
ANEB
|
+$16.6M |
| 2 |
Stoneridge
SRI
|
+$2.63M |
| 3 |
Nektar Therapeutics
NKTR
|
+$2.58M |
| 4 |
UNIFI
UFI
|
+$1.43M |
| 5 |
Culp Inc
CULP
|
+$166K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 42.19% |
| 2 | Healthcare | 40.65% |
| 3 | Consumer Discretionary | 8.29% |
| 4 | Financials | 3.74% |
| 5 | Technology | 2.91% |
Similar funds
TA
AFM
SCM
AWM
AGP
SIM
AC
ECM
22NW LP's Q4 2024 Portfolio in Review
As of Q4 2024, 22NW LP held 16 positions worth $159M, up 33% from $119M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
22NW LP deployed $23.4M of net new capital in Q4 2024, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was Stoneridge: 342,787 shares worth $2.15M.
By sector, the portfolio is most concentrated in Industrials at 42% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 22NW LP's largest Q4 2024 buy was Stoneridge: 342,787 shares worth $2.15M.
- 22NW LP added most to Anebulo Pharmaceuticals in Q4 2024, an estimated $16.6M increase.
- 22NW LP's ten largest holdings make up 93% of its $159M portfolio in Q4 2024.
- 22NW LP opened 3 new positions and closed 0 in Q4 2024.
- 22NW LP's portfolio value rose 33% quarter-over-quarter to $159M.
Based on 22NW LP's 13F filing for Q4 2024, filed 14 Feb 2025.